New Start/Stop Automation Available for Mission-Critical SAP® Applications Running on Virtustream Enterprise Cloud
9.9.2020 14:00:00 EEST | Business Wire | Press release
Virtustream, an enterprise-class cloud company and Dell Technologies business, announced the availability of new start/stop automation for SAP® software landscapes and systems to help enterprises optimize their costs and controls through new self-service tools and step-by-step status updates. The functionality is now available in the Virtustream Enterprise Cloud via the xStream portal.
“Virtustream consistently drives new innovation into its Virtustream Enterprise Cloud platform to meet our demanding requirements and evolving mission-critical needs in the cloud,” says Ettore Tenaglia, Head of Service Operations, Almaviva. “The new automated features and tools help to improve our oversight, management and controls of our SAP environments, allowing us to optimize our processes to save valuable time and costs which can go back into our business.”
Address Compute Costs with Workload Automation
Virtustream’s new automated services reduce the amount of time and manual effort required from an organization’s internal IT team to perform start/stop commands on SAP landscapes and systems. The new tools and features include:
- Strategic Scheduling: Start/stop operations can be scheduled through the Virtustream xStream portal in 30-minute windows on a one-time, on-demand, or recurring basis (daily, weekly or free-form). Additionally, users can set an expiration date for the agentless operation. Creating customized schedules to power virtual machines on or off helps to reduce compute costs. Additionally, automatically shutting down applications when they aren’t being used, such as during weekends and maintenance periods, can further optimize costs.
- Defined Prioritization: Customers can assign each SAP system a set priority, allowing them to stagger the start/stop of their system so they proceed in a defined order, helping to ensure applications run efficiently and correctly.
- Improved Access Control: Only approved administrators or users can access and use the start/stop automation, as dictated by the enterprise’s permission controls within their xStream tenant.
- New Status Updates, Customized Notifications and Action Logs: A new status bar indicates the step-by-step process of each action as it progresses through the SAP system or landscape. Additionally, customized email notifications can be sent to each administrator based on actions (all actions or only scheduled) or by result (all results or failed only). An action log is generated for each system that shows all actions run on a specific SAP system or landscape including who initiated the action, when it was completed, and what actions were taken.
“Automation is key to streamlining IT operations and increasing cloud agility while freeing internal resources to focus on higher-priority projects or initiatives,” says Mike Zolla, Vice President of Cloud Platform Engineering and Delivery, Virtustream. “By extending automation deeper into our mission-critical Virtustream Enterprise Cloud platform, we are helping our enterprise customers increase the economic and business benefits of their SAP applications.”
Backed by Virtustream’s extensive experience migrating, optimizing and managing SAP workloads in the cloud, Virtustream’s new start/stop automation capability is available across all xStream-supported databases. Virtustream’s xStream Management Platform provides a powerful cloud management platform with a single interface across complex, distributed IT environments. xStream delivers economic and business benefits for a broad range of mission-critical enterprise applications in the cloud.
About Virtustream
Virtustream LLC, a Dell Technologies business, is the enterprise-class cloud company that is trusted by organizations worldwide to migrate and run their mission-critical applications in the cloud. For enterprises, service providers, healthcare organizations and government agencies, Virtustream’s xStreamCare professional and managed services, and the xStream® Management Platform and Infrastructure-as-a-Service (IaaS) meet the security, compliance, performance, efficiency, and consumption-based billing requirements of complex production applications in the cloud – whether private, public or hybrid.
Virtustream is a trademark of Virtustream LLC. Other trademarks may be trademarks of their respective owners.
SAP and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP SE in Germany and other countries. Please see https://www.sap.com/copyright for additional trademark information and notices.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200909005255/en/
Contact information
For press inquiries:
See the Virtustream newsroom
Frank E. Smith
Head of Global Communications, Virtustream
Frank.E.Smith@Virtustream.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Compass Pathways Launches ‘Change the Tune in TRD’ in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 202615.9.2026 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today announced the launch of Change the Tune in TRD, a new U.S. HCP disease education initiative, to deepen understanding and increase recognition of TRD. The campaign explores the neurobiology of this distinct form of depression and is designed to help navigate care pathways for patients and providers. Change the Tune in TRD was developed to provide evidence-based education to U.S. HCPs on the longer, more persistent episodes associated with TRD, alongside cognitive and emotional patterns, including getting stuck in negative or repetitive ways of thinking, difficulty shifting perspective or navigating emotions, and feeling disconnected from pleasure or motivation1-8. While TRD originates as MDD, its burden and resistance to standard treatments distinguish it as a more complex condition. Compared to MDD, TRD patients experience almost 3x long
NIQ Launches Digital Purchase GeoAudiences Across Europe15.9.2026 13:00:00 EEST | Press release
NIQ (NYSE: NIQ), a leading consumer intelligence company, today announced the launch of Digital Purchase GeoAudiences across five European markets. The new solution extends NIQ’s geographic audience capabilities into digital-first categories including travel, automotive, technology, telecommunications and financial services. The launch expands NIQ’s GeoPurchase offering, which currently provides syndicated audiences across 13 international markets. Digital Purchase GeoAudiences address growing demand from advertisers for purchase-informed audience intelligence across a broader range of digital-first industries and shopping environments. By combining NIQ’s digital commerce intelligence with its GeoPurchase framework, the solution helps advertisers identify geographic areas showing stronger digital shopping activity. Marketers can use these signals to inform where they plan and prioritize media investment. “Marketers shouldn’t have to guess where demand is coming from before they invest,
QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly to Advance Nucleic Acid Therapies for Central and Peripheral Nervous System Diseases15.9.2026 13:00:00 EEST | Press release
QurCan Therapeutics (“QurCan”), a biotechnology company pioneering non-viral, polymer-lipid nanoparticle (PLNP) delivery of genetic medicines through its proprietary TERP™ (Target-Engineered Responsive Polymer) platform, today announced an exclusive research and collaboration agreement with Eli Lilly and Company (“Lilly”) for the treatment of diseases of the central nervous system (CNS) and peripheral nervous system (PNS). Lilly and QurCan will collaborate on multiple research programs focused on the development of PLNP-enabled genetic medicine therapeutics for CNS and PNS delivery. Through this collaboration, QurCan will be responsible for optimizing genetic medicine therapeutics using its TERP platform, and Lilly will be responsible for further research, clinical development, and commercialization of the selected programs. “This collaboration with Lilly represents a validation of our PLNP technology platform and its potential to address some of the most challenging delivery problems
Axo Longevity Raises Oversubscribed $5M Seed Round to Build Europe’s Leading Preventive Health Membership15.9.2026 12:16:00 EEST | Press release
Axo Longevity today announced the close of an oversubscribed $5M seed round to expand its preventive health membership across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260910642125/en/ Axo Longevity preventive health membership The round was backed by MS&AD Ventures, Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital and NIAN Sports & Entertainment, alongside angel investors including Dr. Jorge Planas of Clinica Planas Barcelona and Daniel Kulle, former President of H&M and former CEO of Forever 21. Developed to help people understand what is happening inside their body before symptoms appear, Axo Longevity moved from build to live operations in just twelve weeks. The platform is expanding globally, now operating in the United Kingdom, Ireland, Spain, Germany, and the Netherlands, as well as in its first Latin American market, Peru. It is supported by more than 1,400 laboratory
Chiesi Appoints David Khougazian as Group Chief Executive Officer to Lead the Next Phase of Innovation-Driven Growth15.9.2026 12:00:00 EEST | Press release
Chiesi Group (Chiesi) today announced the appointment of David Khougazian as Group Chief Executive Officer (CEO), effective 15 October 2026. David joins Chiesi following a distinguished international career spanning more than 25 years across the global healthcare and life sciences sectors. Most recently, he served as Executive Partner, Growth, and Head of Global Engagement at Flagship Pioneering, where he supported the growth and development of science-driven healthcare companies and worked closely with leadership teams on long-term value creation, partnerships, financing and organizational development. Following a thorough selection process led by the Board of Directors, David will succeed Interim Group CEO Jean-Marc Bellemin, who has successfully led the Group since 15 May 2026, while also continuing in his permanent role as Group CFO. Maria Paola Chiesi, Chiesi Group Chair, commented: “We are delighted to welcome David to Chiesi at a time of strong momentum for the company. Innovati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
